AG
JANX icon

Algert Global’s Janux Therapeutics JANX Stock Holding History

Algert Global’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.1M Buy
1,110,889
+667,492
+151% +$9.67M 0.2% 121
2026
Q1 		$6.16M Buy
443,397
+260,030
+142% +$3.57M 0.09% 375
2025
Q4 		$2.53M Buy
183,367
+95,150
+108% +$2.24M 0.04% 648
2025
Q3 		$2.16M Sell
88,217
-4,265
-5% -$104K 0.04% 664
2025
Q2 		$2.14M Buy
92,482
+51,822
+127% +$1.37M 0.04% 613
2025
Q1 		$1.1M Sell
40,660
-24,301
-37% -$916K 0.03% 751
2024
Q4 		$3.48M Buy
64,961
+40,489
+165% +$2.14M 0.08% 412
2024
Q3 		$1.11M Buy
+24,472
New +$1.06M 0.03% 725

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Algert Global's JANX Position: Q2 2026 in Review

Algert Global increased its Janux Therapeutics (JANX) stake by 151% in Q2 2026, buying an estimated $9.67M and bringing the position to 1,110,889 shares worth $17.1M. The position accounts for 0.2% of the portfolio, ranked #121.

Algert Global first reported a position in JANX in Q3 2024 and has held it in 8 quarters since. 198 funds tracked by Wall St. Rank hold JANX as of Q2 2026.

  • Algert Global held 1,110,889 shares of Janux Therapeutics worth $17.1M as of Q2 2026.
  • Algert Global bought 667,492 Janux Therapeutics shares in Q2 2026, an estimated $9.67M.
  • Janux Therapeutics made up 0.2% of Algert Global's portfolio in Q2 2026, its #121 holding.
  • Algert Global first reported a position in Janux Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • 198 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.